Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and immunogenicity of the V114 pneumococcal vaccine in healthy Japanese infants; the study is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-10-11